PLEKHS1 and thyroid gland carcinoma: The results presented herein reveal that PLEKHS1 is over-expressed in thyroid carcinomas including PTCs and ATCs, and its higher expression is associated with lethal ATCs as well as metastatic PTCs and shorter patient survival.